Results 191 to 200 of about 378,823 (394)
Current approach to diagnosing and treating allergic rhinitis [PDF]
Jiří Nevrlka
openalex +1 more source
ABSTRACT Objective Chronic rhinosinusitis with nasal polyps (CRSwNP) is a persistent inflammatory condition often associated with other type‐2 diseases. Dupilumab, a monoclonal antibody targeting IL‐4Rα, has revolutionized the treatment of severe CRSwNP.
Pietro Orlando +17 more
wiley +1 more source
Validation study of a new chemiluminescent singleplex IgE assay in a set of Italian allergic rhinitis patients [PDF]
Ekaterina Potapova +10 more
openalex +1 more source
The alpha and beta diversity of the nasal microbiome differed among children with allergic rhinitis (AR), nonallergic rhinitis (NAR), and healthy controls (HCs). Compared to HC, AR had more Escherichia‐Shigella, Negativicoccus, and Campylobacter, while NAR had more Dolosigranulum and fewer Enterobacteriaceae.
Kantima Kanchanapoomi +6 more
wiley +1 more source
How Closely Related are Allergic Rhinitis, Asthma, and Chronic Sinusitis? [PDF]
Mahmoud Ghaderi
openalex +1 more source
Morphological Sinus Features and Chronic Rhinosinusitis Risk: A Radiomics Study
ABSTRACT Objectives Anatomical factors of the sinuses significantly impact the progression of chronic rhinosinusitis (CRS). This study aims to investigate the correlation between morphological sinus features and the risk of CRS onset to provide evidence‐based support for clinical management.
Song Luo +4 more
wiley +1 more source
ABSTRACT Nemolizumab, an anti‐interleukin‐31 receptor A monoclonal antibody, has been approved in Japan for treating atopic dermatitis (AD)‐associated pruritus. While it is effective for itch control, nemolizumab‐associated cutaneous adverse events have been increasingly recognized, yet their clinical features remain poorly characterized. In this study,
Wataru Sasaki +24 more
wiley +1 more source
Determination of Interleukin 31 (IL-31) serum levels according to severity of allergic rhinitis
Noor Suryani Mohd Ashari +4 more
openalex +2 more sources

